Atlas Trials

Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC

Clinical trial NCT05433701 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05433701
Sponsor
Jonggi Choi
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2022-08-29
Primary completion
2026-12-31
Enrollment
178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.